MWNA
PDSB icon

Marshall Wace North America’s PDS Biotechnology PDSB Stock Holding History

Marshall Wace North America’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.74M Buy
+116,677
New +$1.45M 0.01% 762

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Marshall Wace North America's PDSB Position: Q3 2021 in Review

Marshall Wace North America opened a new position in PDS Biotechnology (PDSB) in Q3 2021: 116,677 shares worth $1.74M. The stake represents 0.01% of the portfolio and ranks #762 among its holdings.

59 funds tracked by Wall St. Rank hold PDSB as of Q3 2021.

  • Marshall Wace North America held 116,677 shares of PDS Biotechnology worth $1.74M as of Q3 2021.
  • PDS Biotechnology was a new Marshall Wace North America position in Q3 2021.
  • PDS Biotechnology made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #762 holding.
  • 59 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.